Determining the Effectiveness of Remote Monitoring of Cancer Patients With Oral Cancer Treatment Using Caaring® Software

The goal of this clinical trial investigation with device is to determinate the efficacy of the remote monitoring in cancer patients with a software called Caaring® a través del cumplimento terapéutico y de dosis. The main question it aims to answer is if the development of a self-management platform (Caaring®) empowers cancer patients throughout their illness, reducing the number of in-person and telephone visits assisted by specialized medical and nursing staff. For this, researchers will compare the assessments between the two groups. This is a randomized study with two arms. Online telemonitoring group: The follow-up of these patients will be carried out prospectively remotely through the Caaring® platform. And Prospective Control group: The data of these patients are collected prospectively for their routine medical visits for 12 weeks after their inclusion. Caaring group patients must have sufficient technological skills to use a smartphone.

NCT Number	NCT06998888
Lead Sponsor	Persei Vivarium Collaborators: Effice Servicios Para la Investigacion S.L.
Conditions	Cancer
Enrollment	194 participants
Start Date	2025-04-11
Primary Completion	2025-07 (estimated)
Study Completion	2025-08 (estimated)
Updated on ClinicalTrials.gov	2025-05-31